Back to All

CEO of Diaceutics, Peter Keeling shortlisted for Entrepreneur of the Year Award 2018

7 August, 2018


  • He has been named as a finalist in the international category  
  • A total of 24 entrepreneurs are in the running for the coveted title 
  • The world-renowned programme has been running for 21 years 

Peter Keeling, founder and CEO of Irish company Diaceutics, has been announced as one of the finalists for this year’s EY Entrepreneur of the Year award.  

Now in its 21st year and celebrating the theme of ‘Ambition’, the world-renowned programme recognises Ireland’s high-growth business leaders.   

Peter, who founded Diaceutics in 2005, has been named as a finalist in the international category and joins 23 other entrepreneurs in the running for the coveted prize, the winner of which will be revealed in October.  

Diaceutics works with the world’s top pharmaceutical companies and utilises its global network of laboratories to help deliver better testing, more efficient diagnosis and more effective treatment for patients.  

Since inception, the organisation has given more than half a million patients with life-threatening diseases the best possible chance of getting better. It works in the top 10 markets in the world and has enjoyed 60% growth year-on-year for the last three years. 

Peter has driven the organisation since its inception, when he recognised early on the value of precision medicine in terms of drug development and patient care, to its position now as a leader in the industry.   

Speaking about the news, Peter Keeling said: “It is an absolute honour to be named as a finalist in the EY Entrepreneur of the Year programme, which is widely-recognised and well-respected across the globe. To be considered among such a high calibre of entrepreneurs and businesses is incredible.  

“This year’s ‘Ambition’ theme is something that resonates with everyone who works at Diaceutics and makes the achievement extra special. We are a very ambitious organisation which is constantly striving, and succeeding, at getting the right patients to the right treatment at the right time.” 

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.